Figure 1From: Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort studyOverall survival since time of diagnosis by HR status. Note: HR, Hormone receptor. Adjusted by age, race/ethnicity, stage at diagnosis, grade and year of diagnosis.Back to article page